Viewing Study NCT00523432


Ignite Creation Date: 2025-12-24 @ 9:56 PM
Ignite Modification Date: 2025-12-28 @ 6:11 AM
Study NCT ID: NCT00523432
Status: COMPLETED
Last Update Posted: 2013-09-05
First Post: 2007-08-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase I Study of CCI-779 (Temsirolimus) in Combination With Topotecan in Patients With Gynecologic Malignancies
Sponsor: University of Chicago
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module